|
|
|
Portfolio Evaluation
|
Account 123456 DEMO
|
|
|
|
| Realized Gains/Losses: the difference between the proceeds received from the sale of the security and the original cost of the security. |
|
|
|
Realized Gains/Losses |
|
|
|
| Security Name: |
BIO TECHNOLOGY GENERAL CO |
| Cusip: |
123456789 |
| Realized Gain/Loss: |
N/A |
|
|
|
|
|
|
|
|
|
|
|
Open Transaction |
Close Transaction |
|
|
|
|
|
|
| Reference #: |
C123456 |
K12345 |
| Transaction Type: |
TRANSFER IN |
Sale |
| Trade Date: |
N/A |
10/01/1999 |
| Quantity: |
100 |
100 |
| Price: |
$0.00 |
$25.31 |
| Principal: |
$0.00 |
$2,531.25 |
| Commission: |
$0.00 |
$20.00 |
| Fees: |
$0.00 |
$0.00 |
| Total Cost/Proceeds: |
$0.00 |
$2,511.16 |
|
|
|
|
|
Important Information |
|
|
|
NetxModel is not authorized to give tax advice. The information displayed should be considered general reference. Cost basis information for securities acquired prior to activation of the tax lot accounting system or for securities delivered into your account after purchase, has been provided to NetxModel by you. NetxModel makes no representation as to the accuracy of information provided by clients. Total realized and unrealized gains and losses do not include securities for which no cost basis is available. Note: In the absence of instruction to the contrary, sell transactions will be recorded on a first in first out (FIFO) accounting basis. Cost basis may change in the event of the death of an account owner. Consult your attorney or tax advisor for additional information.
|
|
|
|
|
|
